Meetings To Implement Pandemic Response Voluntary Agreement Under Section 708 of the Defense Production Act, 784-785 [2021-28596]

Download as PDF 784 Federal Register / Vol. 87, No. 4 / Thursday, January 6, 2022 / Notices II Proposal Title: Optimized Dry Powder Formulation and Delivery for Inhaled Clofazimine (N01). Date: January 27, 2022. Time: 1:00 p.m. to 3:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G31, Rockville, MD 20892 (Virtual Meeting). Contact Person: Cynthia L. De La Fuente, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G31, Rockville, MD 20852, 240–669–2740, delafuentecl@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: December 30, 2021. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–00008 Filed 1–5–22; 8:45 am] BILLING CODE 4140–01–P National Institute of Allergy and Infectious Diseases Notice of Closed Meeting TKELLEY on DSK125TN23PROD with NOTICE Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; HHS–NIH–CDC–SBIR PHS 2022–1: Development of Diagnostics to Differentiate HIV Infection from Vaccine Induced Seropositivity (Topic 103). Date: February 2, 2022. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G22B, Rockville, MD 20892 (Virtual Meeting). Jkt 256001 [FR Doc. 2022–00009 Filed 1–5–22; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency [Docket ID FEMA–2020–0016] Federal Emergency Management Agency, Department of Homeland Security. ACTION: Announcement of meetings. AGENCY: National Institutes of Health 18:13 Jan 05, 2022 Dated: December 30, 2021. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. Meetings To Implement Pandemic Response Voluntary Agreement Under Section 708 of the Defense Production Act DEPARTMENT OF HEALTH AND HUMAN SERVICES VerDate Sep<11>2014 Contact Person: Kristina S. Wickham, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G22B, Rockville, MD 20852, 301–761–5390, kristina.wickham@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) The Federal Emergency Management Agency (FEMA) is holding a series of meetings, under the Plan of Action to Establish a National Strategy for the Coordination of National Multimodal Healthcare Supply Chains to Respond to COVID–19, to implement the Voluntary Agreement for the Manufacture and Distribution of Critical Healthcare Resources Necessary to Respond to a Pandemic. DATES: • Wednesday, January 5, 2022, from 1 p.m. to 3 p.m. Eastern Time (ET). • Wednesday, January 12, 2022, from 1 p.m. to 3 p.m. ET. • Wednesday, January 19, 2022, from 1 p.m. to 3 p.m. ET. • Wednesday, January 26, 2022, from 1 p.m. to 3 p.m. ET. FOR FURTHER INFORMATION CONTACT: Robert Glenn, Office of Business, Industry, Infrastructure Integration, via email at OB3I@fema.dhs.gov or via phone at (202) 212–1666. SUPPLEMENTARY INFORMATION: Notice of these meetings is provided as required by section 708(h)(8) of the Defense Production Act (DPA), 50 U.S.C. 4558(h)(8), and consistent with 44 CFR part 332. SUMMARY: PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 The DPA authorizes the making of ‘‘voluntary agreements and plans of action’’ with representatives of industry, business, and other interests to help provide for the national defense.1 The President’s authority to facilitate voluntary agreements with respect to responding to the spread of COVID–19 within the United States was delegated to the Secretary of Homeland Security in Executive Order 13911.2 The Secretary of Homeland Security further delegated this authority to the FEMA Administrator.3 On August 17, 2020, after the appropriate consultations with the Attorney General and the Chairman of the Federal Trade Commission, FEMA completed and published in the Federal Register a ‘‘Voluntary Agreement, Manufacture and Distribution of Critical Healthcare Resources Necessary to Respond to a Pandemic’’ (Voluntary Agreement).4 Unless terminated earlier, the Voluntary Agreement is effective until August 17, 2025, and may be extended subject to additional approval by the Attorney General after consultation with the Chairman of the Federal Trade Commission. The Agreement may be used to prepare for or respond to any pandemic, including COVID–19, during that time. On December 7, 2020, the first plan of action under the Voluntary Agreement—the Plan of Action to Establish a National Strategy for the Manufacture, Allocation, and Distribution of Personal Protective Equipment (PPE) to Respond to COVID– 19 (PPE Plan of Action)—was finalized.5 The PPE Plan of Action established several sub-committees under the Voluntary Agreement, focusing on different aspects of the PPE Plan of Action. On May 24, 2021, four additional plans of action under the Voluntary Agreement—the Plan of Action to Establish a National Strategy for the Manufacture, Allocation, and Distribution of Diagnostic Test Kits and other Testing Components to respond to COVID–19, the Plan of Action to 1 50 U.S.C. 4558(c)(1). FR 18403 (Apr. 1, 2020). 3 DHS Delegation 09052, Rev. 00.1 (Apr. 1, 2020); DHS Delegation Number 09052 Rev. 00 (Jan. 3, 2017). 4 85 FR 50035 (Aug. 17, 2020). The Attorney General, in consultation with the Chairman of the Federal Trade Commission, made the required finding that the purpose of the voluntary agreement may not reasonably be achieved through an agreement having less anticompetitive effects or without any voluntary agreement and published the finding in the Federal Register on the same day. 85 FR 50049 (Aug. 17, 2020). 5 See 85 FR 78869 (Dec. 7, 2020). See also 85 FR 79020 (Dec. 8, 2020). 2 85 E:\FR\FM\06JAN1.SGM 06JAN1 TKELLEY on DSK125TN23PROD with NOTICE Federal Register / Vol. 87, No. 4 / Thursday, January 6, 2022 / Notices Establish a National Strategy for the Manufacture, Allocation, and Distribution of Drug Products, Drug Substances, and Associated Medical Devices to respond to COVID–19, the Plan of Action to Establish a National Strategy for the Manufacture, Allocation, and Distribution of Medical Devices to respond to COVID–19, and the Plan of Action to Establish a National Strategy for the Manufacture, Allocation, and Distribution of Medical Gases to respond to COVID–19—were finalized.6 These plans of action established several sub-committees under the Voluntary Agreement, focusing on different aspects of each plan of action. On October 15, 2021, the sixth plan of action under the Voluntary Agreement—the Plan of Action to Establish a National Strategy for the Coordination of National Multimodal Healthcare Supply Chains to Respond to COVID–19—was finalized.7 This plan of action established several subcommittees under the Voluntary Agreement, focusing on different transportation categories. The meetings are chaired by the FEMA Administrator’s delegates from the Office of Response and Recovery (ORR) and Office of Policy and Program Analysis (OPPA), attended by the Attorney General’s delegates from the U.S. Department of Justice, and attended by the Chairman of the Federal Trade Commission’s delegates. In implementing the Voluntary Agreement, FEMA adheres to all procedural requirements of 50 U.S.C. 4558 and 44 CFR part 332. Meeting Objectives: The objectives of the meetings are as follows: 1. Convene the Sub-Committee to Define Requirements under the National Multimodal Healthcare Supply Chains Plan of Action to establish priorities related to the COVID–19 response under the Voluntary Agreement. 2. Gather Sub-Committee Participants and Attendees to ask targeted questions for situational awareness. 3. Identify pandemic-related supply chain issues, information gaps, and areas for potential additional discussion. 4. Identify potential Objectives and Actions which correspond to SubCommittees. These will be held for further discussion under those SubCommittees. Meetings Closed to the Public: By default, the DPA requires meetings held to implement a voluntary agreement or plan of action be open to the public.8 However, attendance may be limited if the Sponsor 9 of the voluntary agreement finds that the matter to be discussed at a meeting falls within the purview of matters described in 5 U.S.C. 552b(c), such as trade secrets and commercial or financial information. The Sponsor of the Voluntary Agreement, the FEMA Administrator, found that these meetings to implement the Voluntary Agreement involve matters which fall within the purview of matters described in 5 U.S.C. 552b(c) and the meetings are therefore closed to the public. Specifically, these meetings may require participants to disclose trade secrets or commercial or financial information that is privileged or confidential. Disclosure of such information allows for meetings to be closed to the public pursuant to 5 U.S.C. 552b(c)(4). The success of the Voluntary Agreement depends wholly on the willing participation of the private sector participants. Failure to close these meetings to the public could reduce active participation by the signatories due to a perceived risk that sensitive company information could be released to the public. A public disclosure of a private sector participant’s information executed prematurely could reduce trust and support for the Voluntary Agreement. A resulting loss of support by the participants for the Voluntary Agreement would significantly hinder the implementation of the Agency’s objectives. Thus, these meeting closures are permitted pursuant to 5 U.S.C. 552b(c)(9)(B). Deanne Criswell, Administrator, Federal Emergency Management Agency. [FR Doc. 2021–28596 Filed 1–5–22; 8:45 am] BILLING CODE 9111–19–P DEPARTMENT OF THE INTERIOR Bureau of Land Management [LLNMF000000.L14400000.ET0000 LXSSG0270000 223L1109AF; NMNM– 144042] Notice of Proposed Withdrawal and Public Meetings; San Juan County, NM AGENCY: Bureau of Land Management, Interior. 8 See 50 U.S.C. 4558(h)(7). individual designated by the President in subsection (c)(2) [of section 708 of the DPA] to administer the voluntary agreement, or plan of action.’’ 50 U.S.C. 4558(h)(7). 9 ‘‘[T]he 6 See 86 FR 27894 (May 24, 2021). See also 86 FR 28851 (May 28, 2021). 7 See 86 FR 57444 (Oct. 15, 2021). VerDate Sep<11>2014 18:13 Jan 05, 2022 Jkt 256001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 ACTION: 785 Notice of proposed withdrawal. At the request of the Bureau of Land Management (BLM) and subject to valid existing rights, the Secretary of the Interior proposes to withdraw 351,479.97 acres of public lands from location and entry under the United States mining laws and from leasing under the mineral leasing laws, but not disposal under the mineral materials laws, for a 20-year term. This notice segregates the lands for up to 2 years from location and entry under the United States mining laws and from leasing under the mineral leasing laws, subject to valid existing rights, initiates a 90-day public comment period on the withdrawal application, and notifies the public that one or more public meetings will be held regarding the application. DATES: Comments and public meeting requests must be received by April 6, 2022. In-person public meetings regarding the withdrawal application will be held on February 23, 2022, from 3:00–4:30 p.m. and 6:00–7:30 p.m. at San Juan College Henderson Fine Arts Building, 4601 College Boulevard, Farmington, New Mexico. All current guidelines issued by the Centers for Disease Control and Prevention and Department of the Interior COVID–19 safety precautions will be strictly enforced. Members of the public are required to pre-register for the in-person event by using the information provided in the FOR FURTHER INFORMATION CONTACT section of this notice. A virtual public meeting will take place on February 24 from 6:00–7:30 p.m. via the Zoom platform. To register for the virtual session, visit https:// blm.zoomgov.com/webinar/register/ WN_79HAmxoxQ-GXRVRBXl5U0w. A notice for public meeting(s) regarding the withdrawal application will be announced in the local newspaper and on the agency websites at least 30 days before the meeting(s). ADDRESSES: All comments should be sent to Sarah Scott, CCNHP Area Withdrawal, Bureau of Land Management Farmington Field Office, 6251 College Blvd. Suite A, Farmington, NM 87402. A map and other information related to the withdrawal application are available at the Bureau of Land Management Farmington Field Office, 6251 College Blvd., Suite A, Farmington, New Mexico 87402. Details are also available on the project ePlanning website: https:// eplanning.blm.gov/eplanning-ui/ project/2016892/510. FOR FURTHER INFORMATION CONTACT: Sarah Scott, BLM Farmington Field SUMMARY: E:\FR\FM\06JAN1.SGM 06JAN1

Agencies

[Federal Register Volume 87, Number 4 (Thursday, January 6, 2022)]
[Notices]
[Pages 784-785]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-28596]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Docket ID FEMA-2020-0016]


Meetings To Implement Pandemic Response Voluntary Agreement Under 
Section 708 of the Defense Production Act

AGENCY: Federal Emergency Management Agency, Department of Homeland 
Security.

ACTION: Announcement of meetings.

-----------------------------------------------------------------------

SUMMARY: The Federal Emergency Management Agency (FEMA) is holding a 
series of meetings, under the Plan of Action to Establish a National 
Strategy for the Coordination of National Multimodal Healthcare Supply 
Chains to Respond to COVID-19, to implement the Voluntary Agreement for 
the Manufacture and Distribution of Critical Healthcare Resources 
Necessary to Respond to a Pandemic.

DATES: 
     Wednesday, January 5, 2022, from 1 p.m. to 3 p.m. Eastern 
Time (ET).
     Wednesday, January 12, 2022, from 1 p.m. to 3 p.m. ET.
     Wednesday, January 19, 2022, from 1 p.m. to 3 p.m. ET.
     Wednesday, January 26, 2022, from 1 p.m. to 3 p.m. ET.

FOR FURTHER INFORMATION CONTACT: Robert Glenn, Office of Business, 
Industry, Infrastructure Integration, via email at [email protected] or 
via phone at (202) 212-1666.

SUPPLEMENTARY INFORMATION: Notice of these meetings is provided as 
required by section 708(h)(8) of the Defense Production Act (DPA), 50 
U.S.C. 4558(h)(8), and consistent with 44 CFR part 332.
    The DPA authorizes the making of ``voluntary agreements and plans 
of action'' with representatives of industry, business, and other 
interests to help provide for the national defense.\1\ The President's 
authority to facilitate voluntary agreements with respect to responding 
to the spread of COVID-19 within the United States was delegated to the 
Secretary of Homeland Security in Executive Order 13911.\2\ The 
Secretary of Homeland Security further delegated this authority to the 
FEMA Administrator.\3\
---------------------------------------------------------------------------

    \1\ 50 U.S.C. 4558(c)(1).
    \2\ 85 FR 18403 (Apr. 1, 2020).
    \3\ DHS Delegation 09052, Rev. 00.1 (Apr. 1, 2020); DHS 
Delegation Number 09052 Rev. 00 (Jan. 3, 2017).
---------------------------------------------------------------------------

    On August 17, 2020, after the appropriate consultations with the 
Attorney General and the Chairman of the Federal Trade Commission, FEMA 
completed and published in the Federal Register a ``Voluntary 
Agreement, Manufacture and Distribution of Critical Healthcare 
Resources Necessary to Respond to a Pandemic'' (Voluntary 
Agreement).\4\ Unless terminated earlier, the Voluntary Agreement is 
effective until August 17, 2025, and may be extended subject to 
additional approval by the Attorney General after consultation with the 
Chairman of the Federal Trade Commission. The Agreement may be used to 
prepare for or respond to any pandemic, including COVID-19, during that 
time.
---------------------------------------------------------------------------

    \4\ 85 FR 50035 (Aug. 17, 2020). The Attorney General, in 
consultation with the Chairman of the Federal Trade Commission, made 
the required finding that the purpose of the voluntary agreement may 
not reasonably be achieved through an agreement having less 
anticompetitive effects or without any voluntary agreement and 
published the finding in the Federal Register on the same day. 85 FR 
50049 (Aug. 17, 2020).
---------------------------------------------------------------------------

    On December 7, 2020, the first plan of action under the Voluntary 
Agreement--the Plan of Action to Establish a National Strategy for the 
Manufacture, Allocation, and Distribution of Personal Protective 
Equipment (PPE) to Respond to COVID-19 (PPE Plan of Action)--was 
finalized.\5\ The PPE Plan of Action established several sub-committees 
under the Voluntary Agreement, focusing on different aspects of the PPE 
Plan of Action.
---------------------------------------------------------------------------

    \5\ See 85 FR 78869 (Dec. 7, 2020). See also 85 FR 79020 (Dec. 
8, 2020).
---------------------------------------------------------------------------

    On May 24, 2021, four additional plans of action under the 
Voluntary Agreement--the Plan of Action to Establish a National 
Strategy for the Manufacture, Allocation, and Distribution of 
Diagnostic Test Kits and other Testing Components to respond to COVID-
19, the Plan of Action to

[[Page 785]]

Establish a National Strategy for the Manufacture, Allocation, and 
Distribution of Drug Products, Drug Substances, and Associated Medical 
Devices to respond to COVID-19, the Plan of Action to Establish a 
National Strategy for the Manufacture, Allocation, and Distribution of 
Medical Devices to respond to COVID-19, and the Plan of Action to 
Establish a National Strategy for the Manufacture, Allocation, and 
Distribution of Medical Gases to respond to COVID-19--were 
finalized.\6\ These plans of action established several sub-committees 
under the Voluntary Agreement, focusing on different aspects of each 
plan of action.
---------------------------------------------------------------------------

    \6\ See 86 FR 27894 (May 24, 2021). See also 86 FR 28851 (May 
28, 2021).
---------------------------------------------------------------------------

    On October 15, 2021, the sixth plan of action under the Voluntary 
Agreement--the Plan of Action to Establish a National Strategy for the 
Coordination of National Multimodal Healthcare Supply Chains to Respond 
to COVID-19--was finalized.\7\ This plan of action established several 
sub-committees under the Voluntary Agreement, focusing on different 
transportation categories.
---------------------------------------------------------------------------

    \7\ See 86 FR 57444 (Oct. 15, 2021).
---------------------------------------------------------------------------

    The meetings are chaired by the FEMA Administrator's delegates from 
the Office of Response and Recovery (ORR) and Office of Policy and 
Program Analysis (OPPA), attended by the Attorney General's delegates 
from the U.S. Department of Justice, and attended by the Chairman of 
the Federal Trade Commission's delegates. In implementing the Voluntary 
Agreement, FEMA adheres to all procedural requirements of 50 U.S.C. 
4558 and 44 CFR part 332.
    Meeting Objectives: The objectives of the meetings are as follows:
    1. Convene the Sub-Committee to Define Requirements under the 
National Multimodal Healthcare Supply Chains Plan of Action to 
establish priorities related to the COVID-19 response under the 
Voluntary Agreement.
    2. Gather Sub-Committee Participants and Attendees to ask targeted 
questions for situational awareness.
    3. Identify pandemic-related supply chain issues, information gaps, 
and areas for potential additional discussion.
    4. Identify potential Objectives and Actions which correspond to 
Sub-Committees. These will be held for further discussion under those 
Sub-Committees.
    Meetings Closed to the Public: By default, the DPA requires 
meetings held to implement a voluntary agreement or plan of action be 
open to the public.\8\ However, attendance may be limited if the 
Sponsor \9\ of the voluntary agreement finds that the matter to be 
discussed at a meeting falls within the purview of matters described in 
5 U.S.C. 552b(c), such as trade secrets and commercial or financial 
information.
---------------------------------------------------------------------------

    \8\ See 50 U.S.C. 4558(h)(7).
    \9\ ``[T]he individual designated by the President in subsection 
(c)(2) [of section 708 of the DPA] to administer the voluntary 
agreement, or plan of action.'' 50 U.S.C. 4558(h)(7).
---------------------------------------------------------------------------

    The Sponsor of the Voluntary Agreement, the FEMA Administrator, 
found that these meetings to implement the Voluntary Agreement involve 
matters which fall within the purview of matters described in 5 U.S.C. 
552b(c) and the meetings are therefore closed to the public.
    Specifically, these meetings may require participants to disclose 
trade secrets or commercial or financial information that is privileged 
or confidential. Disclosure of such information allows for meetings to 
be closed to the public pursuant to 5 U.S.C. 552b(c)(4).
    The success of the Voluntary Agreement depends wholly on the 
willing participation of the private sector participants. Failure to 
close these meetings to the public could reduce active participation by 
the signatories due to a perceived risk that sensitive company 
information could be released to the public. A public disclosure of a 
private sector participant's information executed prematurely could 
reduce trust and support for the Voluntary Agreement.
    A resulting loss of support by the participants for the Voluntary 
Agreement would significantly hinder the implementation of the Agency's 
objectives. Thus, these meeting closures are permitted pursuant to 5 
U.S.C. 552b(c)(9)(B).

Deanne Criswell,
Administrator, Federal Emergency Management Agency.
[FR Doc. 2021-28596 Filed 1-5-22; 8:45 am]
BILLING CODE 9111-19-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.